Related Experiment Videos
[Endolymphatic infusions in oncological patients].
Voprosy Onkologii
|January 1, 1976
Summary
Endolymphatic infusions increase tumor metastasis risk when lymph node barrier function is compromised. Careful consideration of factors affecting lymphatic barrier integrity is crucial during infusions to mitigate this hazard.
Area of Science:
- Oncology
- Lymphatic System Research
- Cancer Metastasis
Context:
- Impaired lymphatic barrier function elevates tumor spread.
- Free-floating tumor cells in lymphatics, particularly the thoracic duct, pose increased risks.
- Use of lymph-dilating agents exacerbates metastasis potential.
Purpose:
- To highlight the increased risk of tumor metastasis associated with endolymphatic infusions.
- To emphasize the critical role of lymphatic barrier function in preventing cancer spread.
- To inform clinical practice regarding the safe administration of endolymphatic therapies.
Summary:
- Endolymphatic infusions are linked to higher tumor metastatization rates when lymph nodes have impaired barrier function.
- The risk is amplified by free tumor cells within the lymphatic system and the use of lymph-dilating substances.
- Comprehensive assessment of factors compromising lymphatic barrier integrity is essential before and during endolymphatic infusions.
Impact:
- Provides critical insights for oncologists and surgeons regarding endolymphatic infusion safety.
- Underscores the importance of preserving lymphatic system integrity in cancer treatment.
- Aims to reduce iatrogenic tumor spread during therapeutic interventions.